Vulnerability in Hospira Plum A+3 Infusion System
CVE-2015-3953
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.020 (79.6th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 80th percentile — 79.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.020 · newest: 0.020 · change: 0.000
Affected products
- Hospira Plum A+3 Infusion System — versions <= 13.6
- Hospira Plum A+ Infusion System — versions <= 13.4
- Hospira Symbiq Infusion System — versions <= 3.13
- Pifzer Plum A\+3 Infusion System
- Pifzer Plum A\+3 Infusion System Firmware
- Pifzer Plum A\+ Infusion System
- Pifzer Plum A\+ Infusion System Firmware
- Pifzer Symbiq Infusion System
- Pifzer Symbiq Infusion System Firmware
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSA-15-161-01 (US Government Resource, Third Party Advisory, Mitigation)
Frequently asked questions
- What is CVE-2015-3953?
- CVE-2015-3953 is a critical-severity vulnerability in Hospira Plum A+3 Infusion System, classified under Use of Hard-coded Password. CVSS score: 9.8/10. Published 2019-03-25.
- How severe is CVE-2015-3953?
- Critical severity. CVSS v3 base score is 9.8 out of 10.